Áß¾Ó´ëÇб³º´¿ø 2022³â Áß¾ÓÀÇ´ë ºñ´¢À¶ÇÕ ¹× ¿À°¡³ëÀÌµå ¼¼¹Ì³ª : 2022-11-11±³À°ÀÏÀÚ : 2022-11-11
±³À°Àå¼Ò : Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦
±³À°ÁÖÁ¦ :
2022³â Áß¾ÓÀÇ´ë ºñ´¢À¶ÇÕ ¹× ¿À°¡³ëÀÌµå ¼¼¹Ì³ªÁÖÃÖ±â°ü : Áß¾Ó´ëÇб³º´¿ø
´ã´çÀÚ : ±èÀºÁÖ
¿¬¶ôó : 02-582-8572
À̸ÞÀÏ :
app@app2010.com ±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª :
°æ±âµµ±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í »çÀüµî·Ï 10¿ù31ÀϱîÁö
app@app2010.com ±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-11 Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦ 12:00~12:10 Formulation strategy for poloxamer-based floating hydrogel ±¸À±ÅÂ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11-11 Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦ 12:10~12:20 Drug and DDS effect on bladder cancer ¸Í¼¼Á¤(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11-11 Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦ 12:20~12:30 Recominant BCG for bladder cancer ÀåÀÎÈ£(Áß¾ÓÀÇ´ë)
Åä·Ð 11-11 Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦ 12:30~13:00 Panel discussion Áöº´ÈÆ ±è¹Ì°æ(Áß¾ÓÀÇ´ë ¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-11 Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦ 13:00~13:10 ¹æ±¤ÀÇ ±â°è°øÇÐÀû ±â´É ¸ð»ç Ç÷§Æû ¹ÚÁß¿(Áß¾Ó°ø´ë)
±³À°½Ã°£ 11-11 Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦ 13:10~13:20 3D bioprint ±â¹Ý bladder cancer on a ChipÀÇ update ÃÖ¼¼¿µ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11-11 Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦ 13:20~13:30 3D bioprint ±â¹Ý kidney cancer on a ChipÀÇ update ÃÖÁß¿ø(°¡Å縯ÀÇ´ë)
Åä·Ð 11-11 Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦ 13:30~14:00 Panel discussion ¼¿½º¹Ì½º ±è¼ºÈ¯ À̿뼺(¼¿½º¹Ì½º Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11-11 Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦ 14:20~14:50 ¿µ¾î³í¹® ÀÛ¼º°ú ¹ßÇ¥¿ä·É ÃÖº´ÀÎ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11-11 Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦ 14:50~15:20 MicroRNA as a diagnostic tool for bladder and prostate cancer ±è¿øÀç(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 11-11 Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦ 15:20~15:30 Ç×¾Ï ¾Æµ¥³ë¹ÙÀÌ·¯½º¸¦ ÀÌ¿ëÇÑ ¹æ±¤¾Ï Ä¡·á À±¾Æ¶÷(ÇѾç°ø´ë)
±³À°½Ã°£ 11-11 Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦ 15:30~15:40 Dendritic cell in prostate cancer ÃÖ¼¼¿µ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11-11 Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦ 15:40~15:50 Mouse model for prostate cancer bone metastasis Å×Á¾Çö(Áß¾ÓÀÇ´ë)
Åä·Ð 11-11 Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦ 15:50~16:20 Panel Discussion °¼º±¸ÀÌÇöÁ¤(°í´ëÀÇ´ëÁß¾ÓÀÇ´ë)
±³À°½Ã°£ 11-11 Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦ 16:20~16:30 Àü¸³¼±¾Ï ÇÑÇöÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-11 Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦ 16:30~16:40 ¿ä·Î»óÇǼ¼Æ÷¾Ï À±¼®Áß(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 11-11 Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦ 16:40~16:50 ½ÅÀå¾Ï °¹Î¿ë(¼º±Õ°üÀÇ´ë)
Åä·Ð 11-11 Áß¾Ó´ëÇб³±¤¸íº´¿ø ±èºÎ¼·È¦ 16:50~17:20 Panel discussion ±èÁø¿í ¹Ú¼ººó(Áß¾ÓÀÇ´ë)